Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Kimberly M. Lovett"'
Publikováno v:
Clinical Therapeutics. 35:694-700
Background Narrow therapeutic index (NTI) drugs, because of proximity of therapeutic amounts to toxic amounts, require close professional oversight, particularly when switching formulations. However, safe use may be compromised by unsupervised switch
Publikováno v:
Contraception. 86:551-556
Background Issues surrounding contraception access have been a national focus. During this debate, adolescent and adult women may seek these products online. Due to safety concerns, including potential counterfeit forms, we wished to assess whether o
Publikováno v:
Journal of Medical Screening. 19:141-153
Objectives Unsupervised online direct-to-consumer (DTC) access to medical services has rapidly expanded to medical screening tests, which have not been critically evaluated for their evidence basis. The objective of this study is to identify the scop
Publikováno v:
Journal of Clinical Oncology. 30:1411-1414
Kimberly M. Lovett, Kaiser Permanente; University of California San Diego School of Medicine; and Institute of Health Law Studies, California Western School of Law, San Diego, CA Bryan A. Liang, University of California San Diego School of Medicine;
Publikováno v:
Ethics in Biology, Engineering and Medicine. 2:253-265
Publikováno v:
Journal of the American Geriatrics Society. 60:398-400
Autor:
Bryan A. Liang, Kimberly M. Lovett
Publikováno v:
Pathology Case Reviews. 17:157-159
Autor:
Bryan A. Liang, Kimberly M. Lovett
Publikováno v:
Patient Safety ISBN: 9781461474180
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37e64e3a11bd4a14d361395d349d3ea1
https://doi.org/10.1007/978-1-4614-7419-7_21
https://doi.org/10.1007/978-1-4614-7419-7_21
Publikováno v:
Contraception. 88(4)
Publikováno v:
Journal of diabetes science and technology. 6(6)
The online, direct-to-consumer (DTC) medical marketplace is proliferating more rapidly than regulation is evolving to ensure proper patient safety and public health controls. Along with this growing body of unrestrained medical testing and pharmaceut